(19)

(11)

EP 4 373 473 A1

(12)

(43) Date of publication: 29.05.2024 Bulletin 2024/22 (21) Application number: 22755145.4 (22) Date of filing: 22.07.2022

(51) International Patent Classification (IPC):  A61K 9/16(2006.01) A61K 9/28(2006.01) A61P 1/00(2006.01) A61K 9/20(2006.01) A61K 9/50(2006.01) A61K 31/4015(2006.01) (52) Cooperative Patent Classification (CPC): A61P 1/00; A61K 9/2027; A61K 9/2866; A61K 9/5047; A61K 9/1635; A61K 9/2054; A61K 9/1694; A61K 31/4015 (86) International application number: PCT/EP2022/070585 (87) International publication number: WO 2023/002004 (26.01.2023 Gazette 2023/04)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 23.07.2021 EP 21382672 (71) Applicant: Neuraxpharm Pharmaceuticals, S.L. 08970 Sant Joan Despí, Barcelona (ES)	(72) Inventors: RIDHURKAR, Devendra 08970 Sant Joan Despí, Barcelona (ES) ÚBEDA PÉREZ, Carmen 08970 Sant Joan Despí, Barcelona (ES) DÍEZ MARTÍN, Ignacio 08970 Sant Joan Despí, Barcelona (ES) (74) Representative: ABG Intellectual Property Law, S.L.  Avenida de Burgos, 16D Edificio Euromor 28036 Madrid 28036 Madrid (ES)